Internal Medicine, Hematology & Oncology · Morristown, NJ
NPI
1396159448
Since 2014
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
465 South St Ste 200
Morristown, NJ, 07960
Phone (973) 971-7206
Groups this clinician bills Medicare through
Medicare paid, 2024
$138K
1,546 services
Medicare patients, 2024
554
Average age 76
Drug cost, 2024
$1.0M
461 prescriptions
Company payments, 2025
$852
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew Stuart was code 99213 (office e&m - established), 318 times for 169 patients. In total Matthew Stuart billed 1,546 services in 18 codes, and Medicare paid $138K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 318 | 169 | $71.06 | $23K |
| 99215 Office E&M - Established | Office | 263 | 124 | $149.58 | $39K |
| 99233 Hospital E&M - Subsequent | Facility | 202 | 126 | $99.83 | $20K |
| 99223 Hospital E&M - Initial | Facility | 182 | 169 | $142.41 | $26K |
| 99214 Office E&M - Established | Office | 136 | 100 | $99.72 | $14K |
| 99232 Hospital E&M - Subsequent | Facility | 77 | 65 | $65.39 | $5,035 |
| 99205 Office E&M - New | Office | 40 | 40 | $182.91 | $7,316 |
| 96372 Injection Administration | Office | 36 | 24 | $11.89 | $428 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 30 | 30 | $13.98 | $419 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 29 | 20 | $0.83 | $24.02 |
| 99212 Office E&M - Established | Office | 11 | 11 | $49.65 | $546 |
By year: 2022 $104K for 1,112 services; 2023 $129K for 1,257 services; 2024 $138K for 1,546 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew Stuart prescribed most often to Medicare patients was Eliquis (Apixaban), with 66 prescriptions and refills. In total Matthew Stuart wrote 461 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 66 | 92 | 19 | $54K |
| Sancuso Granisetron | 47 | 47 | 13 | $62K |
| Neulasta Pegfilgrastim | 41 | 41 | Under 11 | $261K |
| Prochlorperazine Maleate Generic | 30 | 30 | 18 | $322 |
| Mirtazapine Generic | 22 | 38 | Under 11 | $340 |
| Procrit Epoetin Alfa | 21 | 21 | Under 11 | $86K |
| Ondansetron Hcl Generic | 14 | 14 | Under 11 | $706 |
| Neulasta Onpro Pegfilgrastim | 13 | 13 | Under 11 | $82K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 12 | 13 | 11 | $194 |
| Xarelto Rivaroxaban | 12 | 28 | Under 11 | $16K |
| Valacyclovir Valacyclovir Hcl | 11 | 21 | Under 11 | $201 |
Brand drugs: 256 claims; generic drugs: 205 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew Stuart $852 ($852 in general payments such as food, travel and fees) from 25 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $83.01.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 2 | $83.01 |
| Array Biopharma Inc PFE | 4 | $72.8 |
| Merck Sharp & Dohme LLC MRK | 3 | $60.3 |
| Genentech USA, Inc. ROG.SW | 3 | $58.28 |
| Abbvie Inc. ABBV | 3 | $48.62 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $44.68 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $41.04 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $37.56 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $35.96 |
| Daiichi Sankyo Inc. 4568.T | 2 | $35.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.